Moving towards Universal Coverage of Direct-Acting Antiviral Therapies for Hepatitis C Infection in Canada: An Environmental Scan of Canadian Provinces and International Jurisdictions

• Ngā kaituhi matua: Samantha Myers (Author), Gurleen Khosa (Author), I fan Kuo (Author), Donica Janzen (Author), Silvia Alessi-Severini (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2018-11-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Direct-acting antivirals (DAAs) have become the standard treatment for patients with chronic hepatitis C infections because of their high cure rates and favourable side effect profiles; however, access to this new class of agents has been limited because of its high cost.  Public payers...